No warrant proceeds used during quarter ended September 30, 2026

Compliance View source PDF Explain this filing

Price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close

-0.7%Reaction day

₹415.00

prior close

—

announcement price

After-mkt

timing

Nifty Microcap 250market · in no size index; the smallest one is usedpendingvs market: pending

Pharmaceuticals peers, median of 171sector+0.5%-1.2% vs sector

On the reaction day the stock moved 1.2 pts less than its Pharmaceuticals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark

Stock

—

10m

—

15m

—

30m

—

Sessions after the filingfrom the prior close

StockMarketvs marketSectorvs sector

Reaction day

-0.7pendingpending+0.5-1.2

Next day

+1.2pendingpending+0.4+0.8

—————

15d

—————

UpDownMarket · Nifty Microcap 250Sector · Pharmaceuticals peers, median of 171Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Acuite Ratings and Research reported that Transchem did not use any money raised through the preferential issue of warrants during the quarter ended September 30, 2026. The Audit Committee reviewed the report and the Board recorded it on November 4, 2026.

Likely market impact

No proceeds were deployed during the quarter, so continued non-use may delay the stated objectives of the warrant issue.